Dumaghan, Lanielyn C.

HRN: 28-56-69  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/18/2026
CO-AMOXICLAV 625MG (TAB)
02/18/2026
02/24/2026
PO
625mg
TID
SP NSVD With Perineal Repair
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Reproductive Tract    Compliance to guidelines: Compliant To Guidelines